The VP will lead the overall strategy, commercialization, and P&L performance of the rare disease franchise, including the launch of RGX-202. They will partner with executive leadership to drive cross-functional alignment and represent the rare disease community in company-wide growth strategies.
The Head of Sales will oversee the commercial field strategy, execution, and revenue growth for the company's rare disease portfolio. This role involves leading and developing high-performing field teams while partnering with cross-functional departments to ensure successful product launches and patient access.
The Associate Director will lead global regulatory strategy for therapeutic areas from early development through marketing authorization. They will manage critical submission activities, partner cross-functionally, and represent the company in interactions with global health authorities.
The Director will build and lead data, advanced analytics, and forecasting capabilities to support commercial decision-making and launch readiness. They are responsible for designing measurement frameworks, managing complex commercial datasets, and translating analytical findings into actionable recommendations for senior leadership.
The Director will drive regional strategy and commercial launch readiness for rare and neuromuscular disease therapies. They will lead strategic engagement with key stakeholders and treatment centers to ensure alignment with corporate go-to-market objectives.
Design and execute the enterprise data architecture strategy to support commercial growth and scalable data warehousing. Lead the integration of internal and third-party data while establishing governance, quality, and privacy controls across multiple business functions.
